Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has issued an update.
MindBio Therapeutics Corp. has announced the completion of its Booze AI software, a groundbreaking voice-activated, AI-powered blood alcohol estimator designed for smartphones and computers. This innovative tool, which stems from clinical trials using MindBio’s proprietary microdose formulation of LSD, aims to educate users about the risks of alcohol consumption and deter drink driving by providing accurate blood alcohol concentration predictions and performance impairment assessments.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biopharma/biotechnology company focused on developing novel and effective mental health treatments.
Average Trading Volume: 145,376
Technical Sentiment Signal: Sell
Find detailed analytics on MBIO stock on TipRanks’ Stock Analysis page.